HBM Healthcare Investments AG (CH001262) | Finanzwire

Basculer en Français

8296	Companies
114902	Keywords
55332	Articles
62460	Press releases

Headlines Articles Press releases HBM Healthcare Investments AG

Home
Companies
HBM Healthcare Investments AG

BRIEF

published on 10/14/2024 at 06:35, 1 month 7 days ago

Upstream Bio Raises $255 Million in IPO Success

Biotechnology IPO HBM Healthcare Upstream Bio Verekitug
PRESS RELEASE

published on 10/14/2024 at 06:30, 1 month 7 days ago

HBM portfolio company Upstream Bio raises USD 255 million in successful initial public offering
Upstream Bio, backed by HBM Healthcare Investments, raises USD 255 million in successful Nasdaq IPO, focusing on inflammatory disease treatments

Biotechnology HBM Healthcare Investments IPO Inflammatory Diseases Upstream Bio
BRIEF

published on 10/01/2024 at 17:52, 1 month 19 days ago

HBM Healthcare Investments Reports Key Figures for September 2024

Financial Performance Net Asset Value HBM Healthcare Investments Share Price Monthly Figures
BRIEF

published on 10/01/2024 at 17:51, 1 month 19 days ago

HBM Healthcare Investments Reports CHF 23 Million Half-Year Profit for 2024/2025

Financial Results Currency Effects Asset Value HBM Healthcare Half-year Profit
PRESS RELEASE

published on 10/01/2024 at 17:47, 1 month 19 days ago

Key Figures 30.9.2024
HBM Healthcare Investments AG reports key figures as of September 30, 2024, showing positive performance. Monthly and year-to-date performance data in CHF

Performance HBM Healthcare Investments AG Key Figures CHF September 30, 2024
PRESS RELEASE

published on 10/01/2024 at 17:46, 1 month 19 days ago

HBM Healthcare Investments posts half-year profit of CHF 23 million for 2024/2025 financial year; currency effects had a strong negative impact on the result
HBM Healthcare Investments AG reports CHF 23 million profit in 2024/2025 first half, impacted by negative currency effects. NAV per share and share price increased

HBM Healthcare Investments Financial Year Currency Effects Profit NAV Increase
BRIEF

published on 09/16/2024 at 17:52, 2 months 4 days ago

HBM Healthcare Investments AG Reports Key Figures for September 2024

Net Asset Value Share Price Financial Metrics Healthcare Investments September Performance
PRESS RELEASE

published on 09/16/2024 at 17:47, 2 months 4 days ago

Key Figures 15.9.2024
HBM Healthcare Investments AG releases key financial figures for September 15, 2024, showing mixed performance with a decrease in share price and positive NAV growth

Performance Financial Figures HBM Healthcare Investments AG Share Price NAV Growth
BRIEF

published on 09/02/2024 at 17:51, 2 months 18 days ago

HBM Healthcare Investments AG Releases Key Figures for August 2024

Net Asset Value HBM Healthcare Investments Financial Figures Share Price August 2024
PRESS RELEASE

published on 09/02/2024 at 17:46, 2 months 18 days ago

Key Figures 31.8.2024
HBM Healthcare Investments AG reports key performance figures as of 31.08.2024 including NAV, share price, and total net assets in CHF

HBM Healthcare Investments AG Share Price NAV CHF Performance Figures

Accesswire

Published on 11/21/2024 at 13:30, 13 minutes ago

AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 13:30, 13 minutes ago

Datametrex Secures Additional P.O. Approx $250K for IT Services
Published on 11/21/2024 at 13:00, 43 minutes ago

Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 43 minutes ago

Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 43 minutes ago

Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 13:15, 28 minutes ago

NOTICE OF ANNUAL GENERAL MEETING
Published on 11/21/2024 at 12:35, 1 hour 8 minutes ago

audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 28 minutes ago

Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 12:06, 1 hour 37 minutes ago

IVU AG publishes Quarterly Report Q3-2024
Published on 11/21/2024 at 12:00, 1 hour 43 minutes ago

Holding(s) in Company

Les Echos

Published on 11/21/2024 at 06:58, 6 hours 45 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 23 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 19 hours 58 minutes ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 19 hours 58 minutes ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 5 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE